⌘K

Login Start Free

Home/Filings/4/0001213900-24-001958

4//SEC Filing

Pavell Jeff 4

Accession 0001213900-24-001958

CIK 0001711786other

View on SEC.gov Company Profile

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 5:01 PM ET

Size

5.4 KB

Accession

0001213900-24-001958

Insider Transaction Report

Form 4

Period: 2024-01-05

Hoth Therapeutics, Inc.HOTH

Director

Transactions

Award
Options
2024-01-05+25,000→ 25,000 total
Exercise: $1.36From: 2024-01-05Exp: 2034-01-05→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Hoth Therapeutics, Inc.

CIK 0001711786

Entity typeother

Related Parties

1

filerCIK 0001840601

Filing Metadata

Form type: 4
Filed: Jan 7, 7:00 PM ET
Accepted: Jan 8, 5:01 PM ET
Size: 5.4 KB

View on SEC.gov